US Biolab Corporation Biobank

Low density 0.6um tissue microarray block. Source: Pazuzzu, no changes made, Public Domain.

US Biolab Corporation, Inc has a global biobank with access to a diverse range of human biospecimens in various disease states to meet research needs. US Biolab biobank contains more than 500,000 human tissue (FFPE and fresh frozen), tissue array, serum, plasma, whole blood, DNA, and RNA samples. US Biolab Corporation collaborates with major clinical and research centers in the USA, Europe, and Asia to develop collection protocols that are approved by the local Institutional Review Board (IRB) and Ethical Committees and that comply with international and local regulations and guidelines. US Biolab Corporation Biobank customers include major pharmaceutical and biotechnology companies as well as academic and government research organizations.

The biobank covers the following clinical areas:

  • Oncology
  • Hematology-Oncology
  • Benign Tumor Conditions
  • Endocrinology
  • Rheumatology
  • Neurology
  • Pulmonology
  • Cardiology
  • Nephrology / Urology
  • Gastroenterology
  • Hepatology
  • Dermatology
  • Otorhinolaryngology (Ear, Nose, and Throat)
  • Psychiatry
  • Infectious Diseases
  • Obstetrics and Gynecology

US Biolab Corporation can work with partners to create custom biobanks

US Biolab partners with global clinical sites and hospitals from the US, Europe, and Asian countries to create custom biobanks. The company provides the pharmaceutical and biotech industry with consulting, sample collection and analysis services for researchers worldwide.

Featured Partners

The following services are provided:

  • Collection protocol development
  • IRB submission
  • Informed consent form customization
  • Sample Preparation
  • Sample collection, processing and transportation
  • Sample Analysis
  • Case report form implementation
  • Sample storage

The company has expertise in precision medicine and biomedical research projects including biomarker R&D and translational medicine. They have developed more than 300 types of tissue microarray and cell microarray products. Tissue microarrays allow simultaneous analysis of hundreds of tissue samples on one microscope slide in the same amount of time that was previously required for a single specimen. Tissue microarrays increase throughput, conserve precious tissue resources, improve internal experimental controls, and reduce reagent consumption.

 

Sources

  1. http://www.usbiolab.com/

 

advertisement